4.7 Article

ML390 inhibits enterovirus 71 replication by targeting de novo pyrimidine biosynthesis pathway

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Structure, properties of gossypol and its derivatives-from physiological activities to drug discovery and drug design

Yanxia Liu et al.

Summary: This article introduces the bioactivity and regulation mechanisms of gossypol and its derivatives, with a focus on its antitumor mechanism. The design and synthesis of pharmacologically active derivatives based on the structure of gossypol are thoroughly discussed. This review aims to serve as a reference for gossypol-based drug discovery and drug design.

NATURAL PRODUCT REPORTS (2022)

Article Virology

Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy

Pei Liu et al.

Summary: The study confirmed that C4 EV71 vaccines can provide global protection against HFMD, inducing cross-neutralizing antibodies against different sub-genotypes. The results demonstrated that the vaccine can elicit cross-neutralization activities against various sub-genotypes.

VIRUSES-BASEL (2021)

Article Pharmacology & Pharmacy

Reversible covalent inhibitors suppress enterovirus 71 infection by targeting the 3C protease

Meijun Liu et al.

Summary: This study demonstrated the effective antiviral activity of cyanoacrylate and Boc-protected cyanoarylamide derivatives as inhibitors against EV71, showing broad antiviral effects across various cell lines and viral strains. The binding pockets between these inhibitors and 3C(pro) were elucidated through docking studies, providing valuable insights for the development of clinically effective medicines to treat EV71 infections.

ANTIVIRAL RESEARCH (2021)

Review Pharmacology & Pharmacy

Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors leflunomide and teriflunomide in Covid-19: A narrative review

Hardeep Kaur et al.

Summary: DHODH inhibitors have shown promise as antiviral agents against various viruses, including SARS-CoV-2. Studies have shown favorable binding of leflunomide to MPro and spike: ACE2 interface, as well as its involvement in COVID-19 related pathways. Clinical studies have demonstrated the benefits of leflunomide in reducing viral shedding duration, hospital stay duration, and infection severity.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Review Chemistry, Medicinal

Medicinal chemistry strategies toward host targeting antiviral agents

Xingyue Ji et al.

MEDICINAL RESEARCH REVIEWS (2020)

Article Urology & Nephrology

COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor

G. Mjaess et al.

PROGRES EN UROLOGIE (2020)

Editorial Material Cell Biology

Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase

Yechun Xu et al.

PROTEIN & CELL (2020)

Article Hematology

Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant

Anant Gokarn et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)

Article Chemistry, Medicinal

Dihydroorotate dehydrogenase inhibitors in anti-infective drug research

Donatella Boschi et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Pharmacology & Pharmacy

Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer

Joseph T. Madak et al.

PHARMACOLOGY & THERAPEUTICS (2019)

Review Infectious Diseases

Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention

Susanna Esposito et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)

Article Chemistry, Medicinal

Development of ML390: A Human DHODH Inhibitor That Induces Differentiation in Acute Myeloid Leukemia

Timothy A. Lewis et al.

ACS MEDICINAL CHEMISTRY LETTERS (2016)

Article Multidisciplinary Sciences

Human genome-wide RNAi screen reveals host factors required for enterovirus 71 replication

Kan Xing Wu et al.

NATURE COMMUNICATIONS (2016)

Article Virology

Inhibition of Enterovirus 71 by Adenosine Analog NITD008

Cheng-Lin Deng et al.

JOURNAL OF VIROLOGY (2014)

Article Medicine, General & Internal

Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China

Fengcai Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Immunology

EV71 vaccine, an invaluable gift for children

Zhenglun Liang et al.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2014)

Article Chemistry, Medicinal

On Dihydroorotate Dehydrogenases and Their Inhibitors and Uses

Helene Munier-Lehmann et al.

JOURNAL OF MEDICINAL CHEMISTRY (2013)

Article Infectious Diseases

Blocking human enterovirus 71 replication by targeting viral 2A protease

Nisrine Falah et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)

Review Infectious Diseases

Virology, epidemiology, pathogenesis, and control of enterovirus 71

Tom Solomon et al.

LANCET INFECTIOUS DISEASES (2010)

Article Biochemistry & Molecular Biology

Scavenger receptor B2 is a cellular receptor for enterovirus 71

Seiya Yamayoshi et al.

NATURE MEDICINE (2009)

Article Biochemistry & Molecular Biology

Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71

Yorihiro Nishimura et al.

NATURE MEDICINE (2009)

Article Biotechnology & Applied Microbiology

A murine oral enterovirus 71 infection model with central nervous system involvement

YC Chen et al.

JOURNAL OF GENERAL VIROLOGY (2004)